Work

Efficacy of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) on exacerbations and health status in GOLD Group D COPD patients: The FLAME study

Year: 2016

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2016.pa985

Authors: Paul Michael Larbig, Claus Vogelmeier, Nicolas Roche, Tim Ayers, Angel FowlerTaylor, Chau Thach, Anupama Shrinivasan, Robert Fogel, Francesco Patalano, Donald Banerji

Institutions: Novartis (Switzerland), Universitätsklinikum Gießen und Marburg, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Université Paris Descartes, Novartis (United States)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2554782823

Cites:

Cited by:

Related to: 10